Secondary analyses from the SURPASS programme suggest effects on cardiovascular risk markers, including blood pressure and lipid profiles, though these findings should be considered exploratory
CagriSema combines cagrilintide (an amylin analog) with semaglutide, taking a fundamentally different approach by targeting amylin pathways rather than glucagon
For those using CGMs, this process becomes simpler and more comfortable
All participating dogs had previously been recruited based on specified criteria into a 12-month prospective, double-blinded, placebo-controlled randomized clinical trial in which dogs received rapamycin or placebo three times per week for six months
Before the break, document: Current dose
Well list down the potential dangers of combining these two drugs